Back to Search

ELVN

Enliven Therapeutics, Inc. Common Stock
Data: 2026-01-30
$26.45
Price
3.00%
Change
$29.98
52W High
$13.3
52W Low
Buy/Sell Forecast Trendline Why Moving Charts Options

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

Quick Stats
Jan 30, 2026

57.1

AI Score

HOLD

1.38

Volume Ratio

Mar 12, 2026

Next Earnings

17

+ve Days (30d)

13

-ve Days (30d)

ELVN Stock Summary

Last updated Jan 30, 2026

ELVN is currently trading at $26.45, positioned above its 200-day moving average of $20.19, indicating a long-term uptrend. The stock has a 52-week range of $13.3 to $29.98.

Technical Analysis: The 50-day moving average stands at $20.96, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 64.986, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.158, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates ELVN at 57.1/100 with a HOLD recommendation.

ELVN (Enliven Therapeutics, Inc. Common Stock) Indicators

Last updated Jan 30, 2026

Indicator Value
RSI(14) 64.986
CMF (20) 0.158
ROC (10) 5.085
ADX (14) 47.574
Indicator Value
MACD (12,26,9) 1.911
AROONOSC (14) -7.143
WILLAMS %R (14) -41.193
MFI (14) 63.372
ELVN Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

ELVN Price vs Max Options Open Interest
ELVN Max Change In Options Open Interest

ELVN Options - Sort by Max open Interest (near term)

30th January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

ELVN Daily Out of Money Options - Sort by Max open Interest (near term)

30th January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

ELVN Daily In the Money Options - Sort by Max open Interest (near term)

30th January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

ELVN Most Active Options by Volume(near term)

30th January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track

Enliven Therapeutics, Inc. Common Stock is above both 50 Day and 200 Day SMA which is considered Bullish.

ELVN Moving Averages Analysis

Enliven Therapeutics, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026

Enliven Therapeutics, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026

ELVN (Enliven Therapeutics, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Jan 30, 2026

Days MA
10 26.33
20 23.8
30 21.33
50 20.96
100 20.61
200 20.19

ELVN Fundamental Analysis

P/E (Forward) 0
P/E (Trailing) --
Market Cap ($) 1.5 billion
Earnings/Share ($) -1.81
Net Proft Margin (%) 0
Dividend/Share ($) --
EPS Estimate Current Year ($) -1.8
EPS Estimate Next Year ($) -1.9786
WallStreet Target Price ($) 41.375
Most Recent Quarter